2018
DOI: 10.1016/j.bbrc.2018.08.079
|View full text |Cite
|
Sign up to set email alerts
|

Identification of human immunodeficiency virus type-1 Gag-TSG101 interaction inhibitors by high-throughput screening

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…For instance, it has been proposed that targeting exosome biogenesis and release may have potential clinical implications for cancer therapy (26). The interaction between viral proteins and the ESCRT machinery has also been proposed as a potential target for antiviral therapy to fight against enveloped viruses (27,28) and also EV-associated naked viruses (29).…”
Section: Discussionmentioning
confidence: 99%
“…For instance, it has been proposed that targeting exosome biogenesis and release may have potential clinical implications for cancer therapy (26). The interaction between viral proteins and the ESCRT machinery has also been proposed as a potential target for antiviral therapy to fight against enveloped viruses (27,28) and also EV-associated naked viruses (29).…”
Section: Discussionmentioning
confidence: 99%
“…We gave special attention to characterizing the interaction of Tsg101 with HIV-1 Gag in our system, because the essential role of Tsg101-Gag binding in HIV-1 replication makes it a potential target for new classes of antiretroviral therapy (27, 28). Similarly, because a number of other enveloped viruses ( e.g.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, this cellular machinery is exploited by retroviruses such as HIV-1 and other enveloped viruses such as Ebola, which rely on the host ESCRT machinery to abscise virus particles from the surface of infected cells (2125). Hijacking of the ESCRT machinery is critical to the replication of these viruses, and this host-pathogen interaction is not targeted by any of the current approved antiviral drugs, so it presents a potential target for new classes of antivirals (2628). The many critical roles of the ESCRT machinery in human health and disease therefore make it imperative to understand the mechanisms of ESCRT function.…”
Section: Introductionmentioning
confidence: 99%
“…This protein-protein interaction thus constitutes an attractive drug target to develop antivirals. Peptidomimetics, including cyclic peptides (Tavassoli et al 2008;Lennard et al 2019) and small molecules (Siarot et al 2018), have indeed been shown to abolish the interaction between HIV-1 Gag and human Tsg101-UEV and to interfere with viral particles release. In addition, prazole-based drugs abolishing the ubiquitin binding function of Tsg101-UEV proved to interfere with the early HIV-1 assembly, independently of its interaction with the HIV-1 Gag PTAP late domain (Strickland et al 2017).…”
Section: Biological Contextmentioning
confidence: 99%